Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation

Journal of Clinical Apheresis

Volumn 25, Issue 5, 2010, Pages 280-286

  Özkurt, Zübeyde Nur ^a   Yeǧin, Zeynep Arzu ^a   Suyani, Elif ^a   Aki, Şahika Zeynep ^a   Acar, Kadir ^a   Yaǧci, Münci ^a   Sucak, Gülsan Türköz ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

ferritin; iron overload; lymphoma; myeloma; platelet; stem cell mobilization

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; CD34 ANTIGEN; FERRITIN;

ADOLESCENT; ADULT; AGED; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONFERENCE PAPER; FEMALE; FERRITIN BLOOD LEVEL; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IRON OVERLOAD; LEUKOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; ARTICLE; AUTOTRANSPLANTATION; BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; MULTIPLE MYELOMA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; FEMALE; FERRITINS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLATELET COUNT; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 79952200347     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20246     Document Type: Conference Paper

References (29)

1. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C,. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
2. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A,. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357.
3. Hartmann O, Le Corroller AG, Blaise D, Michon J, Philip I, Norol F, Janvier M, Pico JL, Baranzelli MC, Rubie H, Coze C, Pinna A, Méresse V, Benhamou E,. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs A randomized, Controlled trial. Ann Intern Med 1997; 126: 600-607. (Pubitemid 27172186)
4. Kuittinen T, Jantunen E,. Blood stem cell mobilization and collection in patients with lynphoproliferative diseases: practical issues. Eur J Haematol 2008; 80: 287-295. (Pubitemid 351347581)
5. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stalla C,. Therapeutic relevance of CD34+ cell dose in blood stem cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360-1377. (Pubitemid 30159857)
6. Ford CD, Green W, Warenski S, Peterson FB,. Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplant 2004; 33: 901-905. (Pubitemid 38660122)
7. Akhtar S, Weshi AE, Rahal M, Khafaga Y, Tbakhi H, Maghfoor I,. Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: a single institutionon result of 168 patients. Leuk Lymphoma 2008; 49: 769-778. (Pubitemid 351517224)
8. Kuittinen T, Nousiainen T, Halonen P, Mahlamaki E, Jantunen E,. Prediction of mobilization failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 907-912. (Pubitemid 38660123)
9. Mendrone A, Arrais CA, Saboya R, Chamone DAF, Dulley FL,. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients. Transfus Apher Sci 2008; 39: 187-192.
10. Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Sweetenham J, Kalaycio M, Copelan E,. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol; in press.
11. Maradei SC, Maiolino A, de Azevedo AM, Colares M, Bouzas LF, Nucci M,. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 2009; in press.
12. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH,. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586-4588. (Pubitemid 46743431)
13. Altes A, Remacha AF, Sarda P, Baiget M, Sureda A, Martino R, Briones J, Brunet S, Canals C,., Sierra J,. Early clinical impact of iron overload in stem cell transplantation. A prospective study. Ann Hematol 2007; 86: 443-447. (Pubitemid 46655483)
14. Park IH, Kim Y, Kim JS, Cheong JW, Song JW, Min YH,. Transfusion- associated iron overload as a predictive factor for stem cell mobilization in patients with haematological malignancies. Transfus Med 2008; 18: 97-103. (Pubitemid 351519478)
15. Gandhi MK, Jestice K, Scott MA, Bloxaham D, Bass G, Marcus RE,. The minimum CD34 thershold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplant 1999; 23: 9-13. (Pubitemid 29050172)
16. Ikeda K, Kozuka T, Harada M,. Factors for PBSC collection efficiency and collection predictors. Transfus Apher Sci 2004; 31: 245-259. (Pubitemid 39535521)
17. Basquiera AL, Abichain P, Damonte JC, Ricchi B, Sturich AG, Palazzo ED, García JJ,. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation. J Clin Apher 2006; 21: 92-95.
18. Pusic I, Jiang SY, Laundua S, Uy GL, Retting MP, Casben AF, Westervelt P, Abbound CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, Dipersio JE,. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant 2008; 14: 1045-1056.
19. Ford CD, Greenwood J, Anderson J, Snow G, Peterson FB,. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony stimulating factor. Transfusion 2006; 46: 193-198. (Pubitemid 43381753)
20. Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M, Frassoni F,. Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 2001; 98: 3249-3255.
21. Fruehauf S, Seggewiss R,. It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement. Br J Haematol 2003; 122: 360-375. (Pubitemid 36951620)
22. Pasricha SR, Grigg A, Catalano J, Leahy M, Underhill C, Arthur C, D'Rozario J, Lowenthal R, Reed K, Spencer A,. A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma. Cancer 2008; 113: 3192-3198.
23. Santoro A, Magagnoli M, Spina M, Pinotti G, Siracusano L, Michieli M, Nozza A, Sarina B, Morenghi E, Castagna L, Tirelli U, Balzarotti M,. Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma. Haematologica 2007; 92: 35-41. (Pubitemid 46232656)
24. Sauotis B, Fraipont V, Baudoux E, Fassotte MF, Hermanne JP, Jerusalem G, Bours V, Bosquee L, Schaaf-Lafontaine N, Paulus JM, Sondag D, Fillet G, Beguin Y,. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Hematologica 1999; 84: 342-349. (Pubitemid 29474349)
25. Hosing C, Saliba RM, Ahlawat S, Körbling M, Kebriaei P, Alousi A, De Lima M, Okoroji JG, McMannis J, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I, Popat U,. Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. Am J Hematol 2009; 84: 335-337.
26. Watts MJ, Ings SJ, Flynn M, Dodds D, Goldstone AH, Linch DC,. Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile. Br J Haematol 2000; 111: 287-291.
27. Cashen AF, Nervi B, Dipersio J,. AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent. Future Oncol 2007; 3: 19-27.
28. Calandra G, McCarty J, McGuirk J, Tricot G, Crocker SA, Badel K, Grove B, Dye A, Bridger G,. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant 2008; 41: 331-338. (Pubitemid 351330727)
29. Bensinger W, DiPersio JF, McCarty JM,. Improving stem cell mobilization strategies: future directions. Bone Marrow Transplant 2009; 43: 181-195.